Viral Hooks
Trending short videosThree peptide stock investment picks
M

@mikes.ai

Instagram · Talking Head Edit

@mikes.ai Peptides are what Ozempic is made of, and most people still think that’s all they do. The same technology is already approved for skin disease and is being developed across cancer, inflammation and a lot more. That’s why people are comparing it to where AI was three years ago. Three stocks stood out to me: 1) The company whose obesity drug is a pill instead of an injection. In a 280 person trial the top dose averaged nearly 27 pounds lost in 13 weeks, and it still hadn’t plateaued when the trial ended. 2) The company that invented a drug Johnson and Johnson now sells. It collects 6 to 10% of every sale, got $50 million the day it was approved, and has up to $580 million in milestones still to come. 3) The telehealth name trading more than 50% below its high. It’s my highest conviction of the three and the one I’m closest to buying. These are early stage names. Trial results and approvals move them hard in both directions, and one of them has no approved product yet. Copying a buy without knowing why isn’t a strategy. If you’d like to know exactly when we buy, comment STOCK and I’ll send you an invite to my Discord community, where we post all our trades and have beaten the market every single month this year. (Not financial advice, do your own research.)

View original on Instagram

The edit1 shot · 6 text
Shots Text1:05

Performance

Views
341.2K
Likes
5.1K
Comments
3K
Engagement
2.4%
Outlier
1.1×
Length · 17 Oct 2026
1:05

Video #46883 · Talking Head Edit

Three peptide stock investment picksfrom @mikes.ai

[01]

Overview

The creator presents a list of three peptide-related stocks he believes have high growth potential. He explains the investment thesis for each company—Viking Therapeutics, Protagonist Therapeutics, and Hims & Hers—using supporting visuals like stock charts and article highlights, and concludes with a call-to-action to join his Discord community for trade alerts.

[02]

Simple outline

  1. 1Make bold value promise
  2. 2Tease the final, best item
  3. 3Present list with proof points
  4. 4Offer exclusive info via CTA

[03]

Related videos

227.9K2.3×Creator gives three stock recommendations@mikes.ai · Buying List453.1K4.2×Market crash is buying opportunity@mikes.ai · Opportunity Explainer82.5KCreator recommends five industry newsletters@orenmeetsworld · Buying List75.6K2.7×Woman on stage sharing startup ideas@dini_inabottle · Guide Carousel2.9M2.2×Mystical character teaches finance basics@thekumarmethod · Breakdown1.5MCreator recommends five other creators@rpn · Rapid Fire Listicle128.1KMoneyball strategy for creator marketing@lukaspakter · Case Study Breakdown720.6K2.4×Five brand content ideas every company should try in 2025@orenmeetsworld · Actionable Resource135.5K59.9×Founder productivity tips list overlay@towaonline · Listicle One Shot279.3K19.9×Split screen supplement stack breakdown@reecebrah · Breakdown86.6K6.8×Split screen lead magnet pitch@reecebrah165.7KTwo tools for viral scripting@iamaayushswamy · Tutorial / How To

[04]

Classification

Format
Talking Head Edit
Concepts
Rapid Fire ListicleBreakdownOpportunity Explainer
Elements
Title Text HookGraphic OverlayB-Roll CutawayDM / Comment-for-Info CTAJump CutImage OverlayVoiceoverText Overlay
Account
Personal Brand
Topics
FinancePersonal FinanceBusinessHealth

[05]

Hook analysis

What stops the scroll in the first 3 seconds

Title hook · 55%

5 Peptide stocks that can 10x in 2026

Verbal hook · 40%

Peptides are going to make people generational wealth this year.

Visual hook · 5%

A medium close-up of the speaker addressing the camera directly with expressive hand gestures, creating a personal and engaging connection.

[06]

Hook template

Steal this for your own video

[number] [hot niche/trend] [things to buy or pick] that can [multiplier or big result] in [future year]

  • — 5 AI chip stocks that can 10x in 2026
  • — 7 under-the-radar Airbnb markets that can double your rental income in 2027
  • — 4 beginner-friendly side hustles that can replace your salary in 2026

[07]

Hook and payoff

The promise the opener makes, and how the video pays it back

Hook

A high-stakes, quantifiable promise about a specific niche, immediately establishing the video's value and potential outcome for the viewer.

Payoff

A call to action that offers exclusive, time-sensitive information ('exactly when we buy') in exchange for a specific engagement action (commenting 'STOCK'), leveraging the credibility and FOMO built throughout the video.

[08]

Narrative framework

The structural pattern this video runs on

Framework

The Escalating Conviction List

Presenting a curated list of items, ordered by increasing personal conviction or value, to hold audience attention until a final, high-engagement call to action.

  1. 1

    The Grand Promise

    State a bold, aspirational outcome (e.g., 'generational wealth', '10x') achievable through the information in the video.

  2. 2

    The Final Item Tease

    Explicitly state that the last item on the list is the most important or the creator's 'highest conviction,' creating a suspense loop that compels viewers to watch to the end.

  3. 3

    The 'Why Now' Analogy

    Justify the topic's importance by defining it and comparing it to a recent, widely understood success story or massive trend (e.g., 'where AI was three years ago') to build credibility and urgency.

  4. 4

    The List Rundown

    Systematically present each of the numbered items using a consistent micro-pattern to deliver value efficiently.

  5. 5

    The Insider Justification

    For the final, most important item, add a layer of social proof or urgency by referencing an exclusive community's knowledge or a time-sensitive opportunity ('getting close to our buy levels').

Themes

  • Investment opportunities
  • Biotechnology trends
  • Wealth creation
  • Stock market analysis

Techniques

  • Direct address
  • Data visualization
  • Social proof
  • Call-to-action

Post caption

Peptides are what Ozempic is made of, and most people still think that’s all they do. The same technology is already approved for skin disease and is being developed across cancer, inflammation and a lot more. That’s why people are comparing it to where AI was three years ago. Three stocks stood out to me: 1) The company whose obesity drug is a pill instead of an injection. In a 280 person trial the top dose averaged nearly 27 pounds lost in 13 weeks, and it still hadn’t plateaued when the trial ended. 2) The company that invented a drug Johnson and Johnson now sells. It collects 6 to 10% of every sale, got $50 million the day it was approved, and has up to $580 million in milestones still to come. 3) The telehealth name trading more than 50% below its high. It’s my highest conviction of the three and the one I’m closest to buying. These are early stage names. Trial results and approvals move them hard in both directions, and one of them has no approved product yet. Copying a buy without knowing why isn’t a strategy. If you’d like to know exactly when we buy, comment STOCK and I’ll send you an invite to my Discord community, where we post all our trades and have beaten the market every single month this year. (Not financial advice, do your own research.)

Text overlays

  • title · beginning

    5 Peptide stocks that can 10x in 2026

  • informational · middle

    Peptide Chain

  • informational · middle

    1. $VKTX

  • informational · middle

    2. $PTGX

  • informational · middle

    3. $SHIMS

  • call-to-action · end

    comment 'STOCK'

Transcript

Peptides are going to make people generational wealth this year. Here are three stocks that can 10 x. And number three is my highest conviction position right now. Peptides are the drugs behind Ozempic and they do far more than weight loss. People are comparing them to where AI was three years ago. First, Viking Therapeutics, a $3,600,000,000 company whose obesity drug is a pill, not an injection. In a trial, patients of the highest dose lost nearly 27 pounds in three months. Its final round of testing starts this year. Second is Protagonist Therapeutics, a $9,000,000,000 company that designs peptides for bigger drug makers. It's the first pill of its kind ever approved, and Johnson and Johnson does the selling. Protagonist just collects up to 10% of every sale. Third is Hims and Hers, which sells treatments online. They now partner directly with Novo Nordisk, the company behind Ozempic. If you've been on our Discord, you know how bullish we are on this one. It's sitting around $30 more than 50% below its high this past year, and it's getting close to our buy levels. If you'd like to know exactly when we buy these, come in stock, and I'll send you an invite to my Discord community, where we best in the market every single month this year and post all our trades.

Three peptide stock investment picks | Viral Hooks